India among 20 countries interested in obtaining Covid-19 vaccine from Russia

11 août 2020
RDIF has seen strong global interest in the vaccine and plans to conduct Phase 3 clinical trials in different countries, including Saudi Arabia, UAE, Brazil, India and Philippines, and start mass production in other countries in partnership with local sovereign wealth funds, including India, (...)
 Site référencé:  The Economic Times

The Economic Times 

Ambuja Cements Q4 Results : Profit doubles to to Rs 1,526 crore on volume growth, cost optimization
1er/05/2024
Technical Breakout Stocks : How to trade Usha Martin, M&M and Trent that hit record highs
1er/05/2024
Ambuja Cements Q4 results : Profit up 6% YoY to Rs 532 cr ; co approves Rs 2 dividend
1er/05/2024
Coal India Q4 Preview : Net profit seen falling QoQ ; strong operational show expected
1er/05/2024
Godrej conglomerate split : How should investors play the listed entities ?
1er/05/2024
Thinking of creating wealth with Birlas ? Here’s how group stocks fared
1er/05/2024